Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer

Kaisa Lehtomäki; Harri Mustonen; Pirkko-Liisa Kellokumpu-Lehtinen; Heikki Joensuu; Kethe Hermunen; Leena-Maija Soveri; Mogens Karsbol Boisen; Christian Dehlendorff; Julia Sidenius Johansen; Caj Haglund; Pia Österlund

doi:10.3390/cancers13153892

Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer

Kaisa Lehtomäki
, Harri Mustonen
, Pirkko-Liisa Kellokumpu-Lehtinen
, Heikki Joensuu
, Kethe Hermunen
, Leena-Maija Soveri
, Mogens Karsbol Boisen
, Christian Dehlendorff
, Julia Sidenius Johansen
, Caj Haglund
, Pia Österlund

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Article number	3892
Journal	Cancers
Volume	13
Issue number	15
Number of pages	16
ISSN	2072-6694
DOIs	https://doi.org/10.3390/cancers13153892
Publication status	Published - Aug 2021
MoE publication type	A1 Journal article-refereed

Fields of Science

colorectal cancer
prognostic biomarker
tumour marker
CEA
CA19-9
IL-6
CRP
YKL-40
post-adjuvant
lead time
C-REACTIVE PROTEIN
CARCINOEMBRYONIC ANTIGEN
FOLLOW-UP
CURATIVE RESECTION
LEVELS PREDICT
RECURRENCE
INTERLEUKIN-6
OXALIPLATIN
BIOMARKER
MARKERS
3122 Cancers

Access to Document

10.3390/cancers13153892

cancers-13-03892Final published version, 1.3 MBLicence: CC BY

Cite this

Lehtomäki, K., Mustonen, H., Kellokumpu-Lehtinen, P.-L., Joensuu, H., Hermunen, K., Soveri, L.-M., Boisen, M. K., Dehlendorff, C., Johansen, J. S., Haglund, C., & Österlund, P. (2021). Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer. Cancers, 13(15), Article 3892. https://doi.org/10.3390/cancers13153892

@article{9f61a48cd7aa4f63a78d3441cfb2c81a,

title = "Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer",

keywords = "colorectal cancer, prognostic biomarker, tumour marker, CEA, CA19-9, IL-6, CRP, YKL-40, post-adjuvant, lead time, C-REACTIVE PROTEIN, CARCINOEMBRYONIC ANTIGEN, FOLLOW-UP, CURATIVE RESECTION, LEVELS PREDICT, RECURRENCE, INTERLEUKIN-6, OXALIPLATIN, BIOMARKER, MARKERS, 3122 Cancers",

author = "Kaisa Lehtom{\"a}ki and Harri Mustonen and Pirkko-Liisa Kellokumpu-Lehtinen and Heikki Joensuu and Kethe Hermunen and Leena-Maija Soveri and Boisen, \{Mogens Karsbol\} and Christian Dehlendorff and Johansen, \{Julia Sidenius\} and Caj Haglund and Pia {\"O}sterlund",

year = "2021",

month = aug,

doi = "10.3390/cancers13153892",

language = "English",

volume = "13",

journal = "Cancers",

issn = "2072-6694",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "15",

}

TY - JOUR

T1 - Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer

AU - Lehtomäki, Kaisa

AU - Mustonen, Harri

AU - Kellokumpu-Lehtinen, Pirkko-Liisa

AU - Joensuu, Heikki

AU - Hermunen, Kethe

AU - Soveri, Leena-Maija

AU - Boisen, Mogens Karsbol

AU - Dehlendorff, Christian

AU - Johansen, Julia Sidenius

AU - Haglund, Caj

AU - Österlund, Pia

PY - 2021/8

Y1 - 2021/8

KW - colorectal cancer

KW - prognostic biomarker

KW - tumour marker

KW - CEA

KW - CA19-9

KW - IL-6

KW - CRP

KW - YKL-40

KW - post-adjuvant

KW - lead time

KW - C-REACTIVE PROTEIN

KW - CARCINOEMBRYONIC ANTIGEN

KW - FOLLOW-UP

KW - CURATIVE RESECTION

KW - LEVELS PREDICT

KW - RECURRENCE

KW - INTERLEUKIN-6

KW - OXALIPLATIN

KW - BIOMARKER

KW - MARKERS

KW - 3122 Cancers

U2 - 10.3390/cancers13153892

DO - 10.3390/cancers13153892

M3 - Article

SN - 2072-6694

VL - 13

JO - Cancers

JF - Cancers

IS - 15

M1 - 3892

ER -